Mathias Sundgren
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Increased susceptibility and volume reduction in deep brain nuclei in primary orthostatic tremor.
Journal: BMJ neurology open
Published: December 15, 2025
Clinical Characteristics of Primary Orthostatic Tremor - a Comprehensive Clinical Assessment of Patients in Sweden.
Journal: Tremor and other hyperkinetic movements (New York, N.Y.)
Published: November 29, 2025
Orthostatic Tremor Is Evoked by Muscle Load Without the Need for Orthostatic Position.
Journal: Movement disorders clinical practice
Published: May 20, 2025
Cortical response to proprioceptive stimulation in primary orthostatic tremor - a magnetoencephalography study.
Journal: Clinical neurophysiology practice
Published: January 15, 2025
[18F]FE-PE2I DAT correlates with Parkinson's disease duration, stage, and rigidity/bradykinesia scores: a PET radioligand validation study.
Journal: EJNMMI research
Published: December 16, 2022
Does Information from the Parkinson KinetiGraph™ (PKG) Influence the Neurologist's Treatment Decisions?-An Observational Study in Routine Clinical Care of People with Parkinson's Disease.
Journal: Journal of personalized medicine
Published: May 01, 2021
On the physiology of cognitive decline in type 1 diabetes.
Journal: Neurophysiologie clinique = Clinical neurophysiology
Published: December 29, 2020
Simplified quantification of [18F]FE-PE2I PET in Parkinson's disease: Discriminative power, test-retest reliability and longitudinal validity during early peak and late pseudo-equilibrium.
Journal: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
Published: September 21, 2020
Mechanism of visual network dysfunction in relapsing-remitting multiple sclerosis and its relation to cognition.
Journal: Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
Published: May 02, 2019
Cognitive function did not improve after initiation of natalizumab treatment in relapsing-remitting multiple sclerosis. A prospective one-year dual control group study.
Journal: Multiple sclerosis and related disorders
Published: May 24, 2016
Last Updated: 09/26/2026